(Q38621957)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26522853%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

title

ADAMs family and relatives in cardiovascular physiology and pathology (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26522853%20AND%20SRC:MED&resulttype=core&format=json

cardiovascular physiology

28 February 2020

main subject

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26522853%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

author name string

Pu Zhang

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26522853%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Carlos Fernandez-Patron

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26522853%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Zamaneh Kassiri

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26522853%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

publication date

29 October 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26522853%20AND%20SRC:MED&resulttype=core&format=json

Journal of Molecular and Cellular Cardiology

28 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26522853%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

volume

93

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26522853%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

page(s)

186-199

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26522853%20AND%20SRC:MED&resulttype=core&format=json

Matrix as an interstitial transport system

28 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Extracellular matrix communication and turnover in cardiac physiology and pathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

The ADAMs family of metalloproteases: multidomain proteins with multiple functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Altered expression of disintegrin metalloproteinases and their inhibitor in human dilated cardiomyopathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Altered expression of ADAMs (A Disintegrin And Metalloproteinase) in fibrillating human atria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Association between plasma ADAMTS-7 levels and ventricular remodeling in patients with acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Metalloprotease-Disintegrins: Links to Cell Adhesion and Cleavage of TNFα and Notch

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Structure, function and evolutionary relationship of proteins containing a disintegrin domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

ADAMs: key components in EGFR signalling and development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

The ADAM metalloproteinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

A genomic analysis of rat proteases and protease inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

ADAMs: modulators of cell–cell and cell–matrix interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Crystal structures of VAP1 reveal ADAMs' MDC domain architecture and its unique C-shaped scaffold

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Crystal structures of catrocollastatin/VAP2B reveal a dynamic, modular architecture of ADAM/adamalysin/reprolysin family proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

The cysteine-rich domain of human ADAM 12 supports cell adhesion through syndecans and triggers signaling events that lead to beta1 integrin-dependent cell spreading

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

The cysteine-rich domain regulates ADAM protease function in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

ADAM12 Is a Four-leafed Clover

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

A secreted form of ADAM9 promotes carcinoma invasion through tumor-stromal interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Human metalloprotease/disintegrin-like (MDC) gene: exon-intron organization and alternative splicing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Catalytic activity of ADAM8, ADAM15, and MDC-L (ADAM28) on synthetic peptide substrates and in ectodomain cleavage of CD23

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

ADAM15 gene structure and differential alternative exon use in human tissues.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Ataxia and peripheral nerve hypomyelination in ADAM22-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Meltrin beta mini, a new ADAM19 isoform lacking metalloprotease and disintegrin domains, induces morphological changes in neuronal cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Intracellular maturation of the mouse metalloprotease disintegrin MDC15.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

The metalloprotease disintegrin ADAM8. Processing by autocatalysis is required for proteolytic activity and cell adhesion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Cloning and characterization of ADAM28: evidence for autocatalytic pro-domain removal and for cell surface localization of mature ADAM28

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Regulation of the alpha-secretase ADAM10 by its prodomain and proprotein convertases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Regulation of ADAM12 cell-surface expression by protein kinase C epsilon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Intracellular processing of metalloprotease disintegrin ADAM12.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

ADAM8/MS2/CD156, an emerging drug target in the treatment of inflammatory and invasive pathologies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Functional analysis of the domain structure of tumor necrosis factor-alpha converting enzyme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Lipid rafts identified as locations of ectodomain shedding mediated by Meltrin beta/ADAM19.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Characterization of growth factor-induced serine phosphorylation of tumor necrosis factor-alpha converting enzyme and of an alternatively translated polypeptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

TACE/ADAM-17 enzymatic activity is increased in response to cellular stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

EGFR signal transactivation in cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Phosphorylation of TNF-alpha converting enzyme by gastrin-releasing peptide induces amphiregulin release and EGF receptor activation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Extracellular signal-regulated kinase phosphorylates tumor necrosis factor alpha-converting enzyme at threonine 735: a potential role in regulated shedding.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Direct activation of TACE-mediated ectodomain shedding by p38 MAP kinase regulates EGF receptor-dependent cell proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE/ADAM-17: a positive feedback mechanism in the RAS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

ERK-mediated phosphorylation of Thr735 in TNFalpha-converting enzyme and its potential role in TACE protein trafficking

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

TNFα shedding in mechanically stressed cardiomyocytes is mediated by Src activation of TACE.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

ADAMs, cell migration and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

The in vitro activity of ADAM-10 is inhibited by TIMP-1 and TIMP-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

The enzymatic activity of ADAM8 and ADAM9 is not regulated by TIMPs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Catalytic properties of ADAM19

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Catalytic properties of ADAM12 and its domain deletion mutants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Catalytic activity of human ADAM33

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

The isolated N-terminal domains of TIMP-1 and TIMP-3 are insufficient for ADAM10 inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Tailoring tissue inhibitor of metalloproteinases-3 to overcome the weakening effects of the cysteine-rich domains of tumour necrosis factor-alpha converting enzyme.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Reactive site mutations in tissue inhibitor of metalloproteinase-3 disrupt inhibition of matrix metalloproteinases but not tumor necrosis factor-alpha-converting enzyme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

TACE activation by MAPK-mediated regulation of cell surface dimerization and TIMP3 association.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

RECK modulates Notch signaling during cortical neurogenesis by regulating ADAM10 activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

The ADAM10 prodomain is a specific inhibitor of ADAM10 proteolytic activity and inhibits cellular shedding events.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Inhibition of the tumor necrosis factor-alpha-converting enzyme by its pro domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

N-glycosylation regulates ADAM8 processing and activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Secreted and membrane-bound isoforms of protease ADAM9 have opposing effects on breast cancer cell migration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

ADAM12 is selectively overexpressed in human glioblastomas and is associated with glioblastoma cell proliferation and shedding of heparin-binding epidermal growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Interaction of the metalloprotease disintegrins MDC9 and MDC15 with two SH3 domain-containing proteins, endophilin I and SH3PX1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Glycosylation of a disintegrin and metalloprotease 17 affects its activity and inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Discovery of novel inhibitors of a disintegrin and metalloprotease 17 (ADAM17) using glycosylated and non-glycosylated substrates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Epigenetic regulation by Z-DNA silencer function controls cancer-associated ADAM-12 expression in breast cancer: cross-talk between MeCP2 and NF1 transcription factor family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Antitumor function of microRNA-122 against hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Epigenetic regulation of the dendritic cell-marker gene ADAM19

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Aberrant transforming growth factor beta1 signaling and SMAD4 nuclear translocation confer epigenetic repression of ADAM19 in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Epigenetic mechanisms silence a disintegrin and metalloprotease 33 expression in bronchial epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

ADAM12 redistributes and activates MMP-14, resulting in gelatin degradation, reduced apoptosis and increased tumor growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

ADAM28 is activated by MMP-7 (matrilysin-1) and cleaves insulin-like growth factor binding protein-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

MT1-MMP inactivates ADAM9 to regulate FGFR2 signaling and calvarial osteogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Matrix metalloproteinase-7 and ADAM-12 (a disintegrin and metalloproteinase-12) define a signaling axis in agonist-induced hypertension and cardiac hypertrophy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

ADAM17 mediates MMP9 expression in lung epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

MMP-2 Mediates Angiotensin II–Induced Hypertension Under the Transcriptional Control of MMP-7 and TACE

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

The disintegrin/metalloprotease ADAM 10 is essential for Notch signalling but not for alpha-secretase activity in fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Adam10 is essential for early embryonic cardiovascular development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

The ectodomain shedding of E-cadherin by ADAM15 supports ErbB receptor activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

A disintegrin and metalloproteinase 15 contributes to atherosclerosis by mediating endothelial barrier dysfunction via Src family kinase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

ADAM15 regulates endothelial permeability and neutrophil migration via Src/ERK1/2 signalling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Tumor-necrosis-factor-alpha-gene-deficient mice have improved cardiac function through reduction of intercellular adhesion molecule-1 in myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Tumor necrosis factor-alpha mediates cardiac remodeling and ventricular dysfunction after pressure overload state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Clinical trials update: RENEWAL (RENAISSANCE and RECOVER) and ATTACH

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

How to RECOVER from RENAISSANCE? The significance of the results of RECOVER, RENAISSANCE, RENEWAL and ATTACH

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Evidence for a critical role of the tumor necrosis factor alpha convertase (TACE) in ectodomain shedding of the p75 neurotrophin receptor (p75NTR).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Purification of ADAM 10 from bovine spleen as a TNFalpha convertase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Identification and characterization of a pro-tumor necrosis factor-alpha-processing enzyme from the ADAM family of zinc metalloproteases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Membrane type 4 matrix metalloproteinase (MMP17) has tumor necrosis factor-alpha convertase activity but does not activate pro-MMP2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

An essential role for ectodomain shedding in mammalian development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

ADAM-mediated ectodomain shedding of HB-EGF in receptor cross-talk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Targeted imaging of the spatial and temporal variation of matrix metalloproteinase activity in a porcine model of postinfarct remodeling: relationship to myocardial dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

TACE/ADAM17 processing of EGFR ligands indicates a role as a physiological convertase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Defective valvulogenesis in HB-EGF and TACE-null mice is associated with aberrant BMP signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

TACE is required for fetal murine cardiac development and modeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Phenotypic analysis of Meltrin alpha (ADAM12)-deficient mice: involvement of Meltrin alpha in adipogenesis and myogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Proteolytic processing of delta-like 1 by ADAM proteases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

A basolateral sorting signal directs ADAM10 to adherens junctions and is required for its function in cell migration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

The ADAMTS (A Disintegrin and Metalloproteinase with Thrombospondin motifs) family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Proteoglycan degradation by the ADAMTS family of proteinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Cloning and characterization of ADAMTS-14, a novel ADAMTS displaying high homology with ADAMTS-2 and ADAMTS-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

ADAMTS-7: a metalloproteinase that directly binds to and degrades cartilage oligomeric matrix protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

ADAMTS-12 associates with and degrades cartilage oligomeric matrix protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Cleavage of the ADAMTS13 Propeptide Is Not Required for Protease Activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Characterization of METH-1/ADAMTS1 processing reveals two distinct active forms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Proprotein convertase furin interacts with and cleaves pro-ADAMTS4 (Aggrecanase-1) in the trans-Golgi network

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Characterization of proADAMTS5 processing by proprotein convertases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Regulation of ADAMTS9 secretion and enzymatic activity by its propeptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Cell-surface processing of the metalloprotease pro-ADAMTS9 is influenced by the chaperone GRP94/gp96

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

ADAMTS4 (aggrecanase-1) activation on the cell surface involves C-terminal cleavage by glycosylphosphatidyl inositol-anchored membrane type 4-matrix metalloproteinase and binding of the activated proteinase to chondroitin sulfate and heparan sulfate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Reactive-site mutants of N-TIMP-3 that selectively inhibit ADAMTS-4 and ADAMTS-5: biological and structural implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

TIMP-3 inhibits the procollagen N-proteinase ADAMTS-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Inhibition of ADAMTS4 (aggrecanase-1) by tissue inhibitors of metalloproteinases (TIMP-1, 2, 3 and 4)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

ADAMTS1 cleaves aggrecan at multiple sites and is differentially inhibited by metalloproteinase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Alpha2-macroglobulin is a novel substrate for ADAMTS-4 and ADAMTS-5 and represents an endogenous inhibitor of these enzymes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

The ADAMTS12 metalloprotease gene is epigenetically silenced in tumor cells and transcriptionally activated in the stroma during progression of colon cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Characterization of a novel epigenetically-silenced, growth-suppressive gene, ADAMTS9, and its association with lymph node metastases in nasopharyngeal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Epigenetic identification of ADAMTS18 as a novel 16q23.1 tumor suppressor frequently silenced in esophageal, nasopharyngeal and multiple other carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Testicular and epididymal ADAMs: expression and function during fertilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Expression and regulation of a disintegrin and metalloproteinase (ADAM) 8 in experimental asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Metalloprotease-disintegrin ADAM8: expression analysis and targeted deletion in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Myocardial infarction induces early increased remote ADAM8 expression of rat hearts after cardiac arrest

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Mice lacking the metalloprotease-disintegrin MDC9 (ADAM9) have no evident major abnormalities during development or adult life.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Deficits in spatial learning and motor coordination in ADAM11-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Developmental regulation and neuronal expression of the cellular disintegrin ADAM11 gene in mouse nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Altered nociceptive response in ADAM11-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

A metalloprotease-disintegrin participating in myoblast fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Evaluation of the contributions of ADAMs 9, 12, 15, 17, and 19 to heart development and ectodomain shedding of neuregulins beta1 and beta2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Characterization of the catalytic activity of the membrane-anchored metalloproteinase ADAM15 in cell-based assays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

The role of the disintegrin metalloproteinase ADAM15 in prostate cancer progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Increased expression of disintegrin-metalloproteinases ADAM-15 and ADAM-9 following upregulation of integrins alpha5beta1 and alphavbeta3 in atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Highly enhanced expression of the disintegrin metalloproteinase MDC15 (metargidin) in rheumatoid synovial tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Potential role for ADAM15 in pathological neovascularization in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Homeostatic effects of the metalloproteinase disintegrin ADAM15 in degenerative cartilage remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Characterization of oxygen-induced retinopathy in mice carrying an inactivating point mutation in the catalytic site of ADAM15.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

An Adam15 amplification loop promotes vascular endothelial growth factor-induced ocular neovascularization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

ADAM15 deficiency attenuates pulmonary hyperpermeability and acute lung injury in lipopolysaccharide-treated mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Characterization of tumor necrosis factor-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Spatially- and temporally-restricted expression of meltrin alpha (ADAM12) and beta (ADAM19) in mouse embryo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Expression analysis of the entire MMP and TIMP gene families during mouse tissue development.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Essential roles of Meltrin beta (ADAM19) in heart development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Meltrin beta expressed in cardiac neural crest cells is required for ventricular septum formation of the heart.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Extracellular matrix and heart development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Proteolytic cleavage of versican during cardiac cushion morphogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Endocardial Brg1 represses ADAMTS1 to maintain the microenvironment for myocardial morphogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

ADAMTS metalloproteases generate active versican fragments that regulate interdigital web regression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Altered versican cleavage in ADAMTS5 deficient mice; a novel etiology of myxomatous valve disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Reduced versican cleavage due to Adamts9 haploinsufficiency is associated with cardiac and aortic anomalies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Adamts9 is widely expressed during mouse embryo development.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

ADAMTS9 is a cell-autonomously acting, anti-angiogenic metalloprotease expressed by microvascular endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Platelet-delivered ADAMTS13 inhibits arterial thrombosis and prevents thrombotic thrombocytopenic purpura in murine models.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

ADAMTS proteases in vascular biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

ADAM8 and its single nucleotide polymorphism 2662 T/G are associated with advanced atherosclerosis and fatal myocardial infarction: Tampere vascular study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Common variation in the ADAM8 gene affects serum sADAM8 concentrations and the risk of myocardial infarction in two independent cohorts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Potential late-onset Alzheimer's disease-associated mutations in the ADAM10 gene attenuate {alpha}-secretase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Polymorphisms of the tumor necrosis factor-alpha (TNF) and the TNF-alpha converting enzyme (TACE/ADAM17) genes in relation to cardiovascular mortality: the AtheroGene study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

ADAM17_i33708A>G polymorphism interacts with dietary n-6 polyunsaturated fatty acids to modulate obesity risk in the Genetics of Lipid Lowering Drugs and Diet Network study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Analysis of ADAM17 polymorphisms and susceptibility to sporadic abdominal aortic aneurysm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Association between ADAMTS1 matrix metalloproteinase gene variation, coronary heart disease, and benefit of statin therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Genetic variation including nonsynonymous polymorphisms of a major aggrecanase, ADAMTS-5, in susceptibility to osteoarthritis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

ADAMTS7 cleavage and vascular smooth muscle cell migration is affected by a coronary-artery-disease-associated variant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Mutations and common polymorphisms in ADAMTS13 gene responsible for von Willebrand factor-cleaving protease activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

The ADAMTS13 metalloprotease domain: roles of subsites in enzyme activity and specificity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

ADAMTS-7 inhibits re-endothelialization of injured arteries and promotes vascular remodeling through cleavage of thrombospondin-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Plasma ADAMTS-13 levels and the risk of myocardial infarction: an individual patient data meta-analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Decreased plasma ADAMTS-13 activity as a predictor of postoperative bleeding in cyanotic congenital heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Upregulation of Nox4 promotes angiotensin II-induced epidermal growth factor receptor activation and subsequent cardiac hypertrophy by increasing ADAM17 expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Ventricular ErbB2/ErbB4 activation and downstream signaling in pacing-induced heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Pathological neovascularization is reduced by inactivation of ADAM17 in endothelial cells but not in pericytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

VEGF-A stimulates ADAM17-dependent shedding of VEGFR2 and crosstalk between VEGFR2 and ERK signaling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Essential role for ADAM19 in cardiovascular morphogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Expression of ADAMTS1 during murine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Dynamic induction of ADAMTS1 gene in the early phase of acute myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Knockout of Adamts7, a novel coronary artery disease locus in humans, reduces atherosclerosis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Cooperation of two ADAMTS metalloproteases in closure of the mouse palate identifies a requirement for versican proteolysis in regulating palatal mesenchyme proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

Complete deficiency in ADAMTS13 is prothrombotic, but it alone is not sufficient to cause thrombotic thrombocytopenic purpura

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.10.031

10.1016/J.YJMCC.2015.10.031

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26522853%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference